PLoS ONE (Jan 2019)

Correction: SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience.

  • Alessandra Mangia,
  • Valeria Piazzolla,
  • Anna Giannelli,
  • Egidio Visaggi,
  • Nicola Minerva,
  • Vincenzo Palmieri,
  • Immacolata Carraturo,
  • Domenico Potenza,
  • Nicola Napoli,
  • Gianfranco Lauletta,
  • Vincenzo Tagarielli,
  • Rosanna Santoro,
  • Ernesto Piccigallo,
  • Sergio De Gioia,
  • Angelo Chimenti,
  • Giuseppe Cuccorese,
  • Antonio Metrangolo,
  • Michele Mazzola,
  • Ernesto Agostinacchio,
  • Giuseppe Mennea,
  • Carlo Sabbà,
  • Marina Cela,
  • Massimiliano Copetti,
  • Ruggiero Losappio

DOI
https://doi.org/10.1371/journal.pone.0223287
Journal volume & issue
Vol. 14, no. 9
p. e0223287

Abstract

Read online

[This corrects the article DOI: 10.1371/journal.pone.0215783.].